Oscor celebrates a groundbreaking addition of 20,000 sqft to its 80,000 sqft Technology and Innovation Center. The facility has been dedicated and named after our founder Dr. Peter Osypka.
Oscor receives FDA clearance and CE mark certified on the newest and most advanced bidirectional steerable guiding sheath designed for transseptal access.
is a low profile, multidirectional steerable guiding sheath, that provides agility and stability through better catheter access and support.
Oscor is launching worldwide next generation peelaway introducer system with hemostatic valve and side port.
The Adelante® SafeSheath® Ultra
is the first valved peel away introducer system featuring low insertion force while providing superior hemostasis.
Available in various product, size, seal and kit configurations, to meet your exact introducer needs. FDA, CE, and Canada approved.
Oscor receives FDA and CE mark clearance on the Adelante ® Breezeway ™ next generation Guiding Sheath with Hemostatic Seal.
With the Adelante ® Breezeway™ Oscor is introducing the next generation of multiple curve delivery sheaths to facilitate the intracardiac placement of diagnostic catheters, interventional devices and EP mapping catheters while providing complete hemostasis on the proximal port side.
Oscor is now offering on an OEM basis CE certified and FDA released peel - away introducers and introducers with hemostatic valve, diagnostic catheters, guiding sheaths, customized catheters, lead subassemblies, and OEM medical components.
Oscor receives FDA clearance on its angiographic diagnostic catheter line ANGIOS
The ANGIOS is a new generation of diagnostic catheter used for coronary angiography, offering exceptionally high flow rate, high torque and curve stability.
Available in several curve and convenient packaging configurations, the ANGIOS diagnostic catheter is available in various sizes including 4F, 5F, 6F and 7F.
New engineering facility
Oscor opens up its new tool shop and engineering facility, it's third in Palm Harbor, FL.
The new facility adds 50,000 sqft of precision tool and mold shop, swiss machining, cleanroom injection molding, extrusion and braiding for catheter engineering and development of medical devices.
Oscor is featuring a new line of interventional coronary and peripheral vascular diagnostic catheters and introducer sheaths. A complete line of interventional catheters and vascular access devices will be presented and the Arab Health Convention in Dubai, United Arab Emirates, January 25-28 and on the ACC 2010 Convention in Atlanta, GA March 14-16.
Oscor receives FDA and CE mark clearance on its line of VENOS balloon occlusion catheters
The VENOS balloon catheter represents the next generation occlusion catheters used for venography procedures, featuring a compliant balloon with sizes ranging from 10 to 15mm in diameter. The Venos balloon is a non latex compliant balloon with proven reliability from Oscor HELIOS balloon product line.
New manufacturing facility
Oscor opens up its third offshore manufacturing facility in the Dominican Republic.
The new facility adds 20,000 sqft of manufacturing cleanroom space to Oscor Caribe’s current 40,000 sqft cleanroom manufacturing space.
With this growth Oscor increases its offshore capacity in cleanroom manufacturing of implantable medical devices, injection molding and turnkey packaging operations.
Oscor is featuring a new line of surgical convenience kits used for Cath lab, EP lab and ER procedures. The complete line of convenient kits and catheters, including next generation guiding and angiography diagnostic catheters will be presented at the HRS 2009 Convention in Boston, MA May 11-13.